South African vaccine manufacture, BIOVAC, is on track to create the largest vaccine manufacturing facility in Africa. It has secured a financing package of one-point eight Billion rands from the International Finance Corporation, the European Commission, and European Investment Bank to build Africa's first end-to-end multi-vaccine manufacturing site in Cape Town. This is aimed at advancing self-reliance in vaccine production for South Africa and the African continent after huge gaps were identified during the COVID-19 pandemic, and the subsequent race to produce and distribute vaccines globally. The Weekend View caught up with  with BIOVAC CEO. Dr. Morena Makhoana to unpack the significance of this deal.. . Meanwhile, the The AIDS Healthcare Foundation has issued a stark warning to the European Union, urging it to stop blocking equity provisions in the final stages of the World Health Organisation (WHO) Pandemic Treaty negotiations starting next week Monday in Switzerland, Geneva. Jon Gericke spoke to Dr Nombuso Madonsela, the country programme director of the AHF